licoisoflavone A
phaseoluteone
Identification
| Name | licoisoflavone A |
| CAS Number | 66056-19-7 |
| FDA UNII | 6O34S2M9VL |
| Molecular Formula | C20 H18 O6 |
| Molecular Weight | 354.35866000 |
| Nikkaji Number | J18.970G |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Soluble in | water, 2.076 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for licoisoflavone A usage levels up to | not for fragrance use. |
| Recommendation for licoisoflavone A flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Potential Uses
Natural Occurrence
Synonyms
3-[2,4-
dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxychromen-4-one
phaseoluteone
2',4',5,7-
tetrahydroxy-3'-(3,3-dimethylallyl)isoflavone
PubMed:
Biological activity of isoflavonoids from Azorella madreporica.
PubMed:
Monitoring of MRP-like activity in human erythrocytes: inhibitory effect of isoflavones.
PubMed:
Inhibitory effects of licoisoflavones A and B and sophoraisoflavone A of Sophra mooracroftiana Beth ex Baker on copper-ion-induced protein oxidative modification of mice brain homogenate, in vitro.
PubMed:
[Isoflavones from Glycyrrhiza eurycarpa].